Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017660
Filing Date
2025-06-18
Accepted
2025-06-18 16:05:21
Documents
2
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 form4-06182025_040613.html 4  
1 form4-06182025_040613.xml 4 3329
2 ex24-06182025_040614.htm EX-24 4335
  Complete submission text file 0001415889-25-017660.txt   9181
Mailing Address NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Business Address
Markel Stacy (Reporting) CIK: 0001734780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 251056863

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)